Form 4: VolitionRx CEO Butera Receives Restricted Stock Units in Lieu of Cash Compensation
SEC Form 4 Filing
CEO of Volition Veterinary, Salvatore Thomas Butera, receives 35,783 restricted stock units (RSUs) in lieu of cash compensation and disposes of 99,350 jointly owned shares.
Summary
- Salvatore Thomas Butera, CEO of Volition Veterinary, received 35,783 restricted stock units (RSUs) on September 1, 2024, under the company's 2015 Stock Incentive Plan.
- These RSUs were awarded in lieu of cash compensation.
- The RSUs vest in three installments of 11,928 units, 11,928 units, and 11,927 units on September 1, 2024, October 1, 2024 and November 1, 2024, respectively, and are also subject to further time-based vesting in a single installment on June 1, 2025, contingent upon continued service.
- Upon vesting, Butera will receive shares of common stock equal to the number of vested RSUs.
- Butera also disposed of 99,350 shares of common stock that are jointly owned with his spouse.
- Following the transaction, Butera beneficially owns 287,783 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The RSU grant is a common practice, but the disposal of shares could raise concerns. The overall impact is likely to be moderate.
Positives
- The award of RSUs to the CEO in lieu of cash compensation could be seen as a positive sign, preserving cash for the company.
Negatives
- The disposal of 99,350 shares of common stock by the CEO could be interpreted negatively by investors.
Risks
- The vesting of RSUs is contingent upon continued service, creating a potential risk if the CEO were to leave the company before the vesting dates.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- Shareholders may be interested in the CEO's transactions as an indicator of management's confidence.
- Employees may view the RSU grant as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 09/01/2024 | Date of RSU award and first vesting installment (11,928 units) |
| 10/01/2024 | Second vesting installment (11,928 units) |
| 11/01/2024 | Third vesting installment (11,927 units) |
| 06/01/2025 | Final vesting installment |
| 09/04/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.